Frontlight ResearchEarly access
Trial site
Hamburgisches Forschungsinstitut fuer chronisch entzuendliche Darmerkrankungen HaFCED e.K.
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis5 trials
- Crohn's disease2 trials
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 2/31 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Abivax S.A.3 trials
- Anaptysbio Inc.1 trial
- Arena Pharmaceuticals Inc.1 trial
- Eli Lilly & Co.1 trial
- Eli Lilly and Company1 trial
Running trials
Recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
Closed trials
Completed
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026